Y-4 to Treat the Postherpetic Neuralgia

Clinical trial NCT07275762 · RECRUITING

Trial details

NCT number: NCT07275762
Sponsor: Neurodawn Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia Y-4 Pregabalin

Start date: 2026-02-02
Primary completion: 2026-07-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.